Roche

Roche
Pharma

Roche’s bispecific-ADC combo keeps lymphoma at bay

The positive Lunsumio-Polivy readout could give Roche another shot at second-line LBCL as its Columvi contends with a regulatory setback.
Angus Liu Jun 23, 2025 10:27am
multiple myeloma cells blood flow cancer blood cancer

AbbVie, Roche fail again in label expansion bid for Venclexta

Jun 16, 2025 4:23pm
Redbrick building with Sarepta name and logo

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Cannes Lions award

Biogen, BMS and Novartis bag spots on Cannes Lions shortlists

Jun 16, 2025 2:14am
David Hung Medivation CEO

With lung cancer FDA nod, it's David versus Goliath

Jun 11, 2025 4:17pm
layoffs cut staff reduction workforce
Favicon Fierce Biotech

Genentech lays off 143 workers at South San Francisco campus

Jun 11, 2025 12:25pm